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Helicobacter pylori infection, often acquired in early childhood, is a global cause of undernutrition, gastritis, peptic ulcer disease
and gastric carcinoma. This study tested the feasibility of using H. pylori shed in the faeces as a source of DNA for non-invasive
epidemiological studies. H. pylori DNA was chemically recovered and isolated using a specific biotinylated oligonucleotide probe
with magnetic capture from 28 H. pylori positive faecal samples obtained from children attending hospital for the investigation
of suspected H. pylori infection, together with close family members. Random amplification of polymorphic DNA (RAPD) was
subsequently used to discriminate each isolate. 93% of stool samples selected were typeable. Parent, child and sibling samples were
compared and similarities determined. Phylogenetic analysis showed that H. pylori DNA obtained from the faeces can be used to
genotype individual strains, oﬀering a means of studying intrafamilial transfer of this microorganism.
1. Introduction
The endemic gram-negative bacterium Helicobacter pylori
colonises the gastric mucosa of up to half of the human pop-
ulation of the world [1]. Although in many cases it causes
nonspecific dyspeptic symptoms or none at all, it is recog-
nised that H. pylori is the principal cause of duodenal ulcer
disease and can ultimately lead to the development of gastric
cancer [2]. Knowledge of the full genome of H. pylori [3]
makes it possible to isolate and genotype H. pylori DNA
from colonized individuals for the purpose of studies of its
distribution and transmission [4].
While many genotyping methods exist, they are generally
performed on DNA samples obtained from the stomach by
endoscopic gastric biopsy or aspiration. Such methods can
be used to determine transmission routes and risk factors [4],
but invasive methods of sampling are unsuitable for epidemi-
ological studies involving young children [5]. Genotyping H.
pylori DNA obtained from faecal samples oﬀers an attractive
non-invasive alternative method for such purposes.
While H. pylori is shed in the faeces, in the majority of
cases, it is either diﬃcult to culture or nonviable [6–8], and
diagnosis is often made by serology based on the presence or
absence of traces of the organism (antigen). This precludes
analysis of the strains present [4]. We published a non-
invasive method designed specifically to obtain H. pylori
from human faeces [4] using a procedure for the organic
extraction of DNA. It is necessary to show that purified H.
pylori DNA extracted from faeces is intact genomic DNA
which can be used for genotyping, oﬀering a potential means
of non-invasive determination of the transmission route of
this microorganism.
Rapid amplification of polymorphic DNA (RAPD) has
been used for epidemiological studies of local bacterial out-
breaks [9]. Several have used RAPD fingerprinting of mate-
rial obtained by gastric biopsy [10, 11] or gastric aspirates
[12] to investigate the transmission of H. pylori, supporting
the hypothesis of intrafamilial transmission. These studies
indicated that there is a high level of sequence diversity
within this microorganism; 64 independent H. pylori isolates
were distinguishable in one study [10], and more recently a
study of 32 cases suggested that family members have closely
related H. pylori fingerprinting patterns [11]. Previously,
RAPD analysis confirmed that children infected with H.
pylori had strains identical to that of their mothers, consistent
with vertical transmission from mother to child [12]. RAPD
is highly discriminatory and, therefore, useful in the inves-
tigation of short term or local outbreaks of disease [10–12].
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Figure 1: Family trees showing H. pylori positive study participants
who provided faecal samples. Circles represent females, and squares
represent males. Older generations are represented above younger
ones. Unshaded symbols represent family members who tested
antigen negative while shaded symbols represent those who tested
antigen positive. Numbered symbols denote subjects from whom
suﬃcient stool remained after HpSA testing to undergo H. pylori
genotyping. Adapted from family tree data (13).
This paper describes a method for extraction and isolation of
DNA from human faeces followed by molecular genotyping.
RAPD was evaluated on samples obtained from infected
children and their immediate family members.
2. Subjects, Materials, and Methods
2.1. Subjects. Children (aged up to 16 years) attending the
Royal Hospital for Sick children (Glasgow, UK) for urea
breath test (UBT) of suspected H. pylori infection were stud-
ied. Those with positive UBT results, together with close
family members, were asked to provide faecal samples. These
were obtained after informed parental consent and under-
went HpSA analysis to determine their H. pylori status
[13]. Twenty-eight positive faecal samples from children
and family members were selected for this methodologi-
cal study (Figure 1). In some cases insuﬃcient stool was
available after HpSA analysis to permit DNA extraction and
genotyping.
2.2. Urea Breath Tests. Duplicate fasting baseline breath sam-
ples were collected by exhaling through a straw into an exe-
tainer (Labco, High Wycome, UK) before and 30 min and at
40 min after oral ingestion of 20 mls of 15% polycose (Abbott
Laboratories, Dublin, Ireland), containing 100 mg 13C urea
(99 atom% excess; CK Gas, Berks, UK). The abundance of
breath 13C was measured by continuous-flow isotope ratio
mass spectroscopy (20/20 PDZ Europa, Crewe, UK). Enrich-
ment was calculated as excess abundance of the 30 min
after 13C urea dose over the baseline reading. A reading of
40.0 ppm (delta over baseline, 3.5% 13C) was determined
diagnostic of H. pylori colonisation [14].
2.3. HpSA Analysis. Faecal samples were frozen at −80◦C
until analysis. An enzyme immunoassay (Premier Platinum
HpSA, Meridian Diagnostics Inc., Cincinnati, USA) was used
to determine the presence or absence of H. pylori antigen.
This serological test relies on the binding of H. pylori
to anti-H. pylori antibodies on microwells in the pres-
ence of peroxidase-conjugated polyclonal antibodies [13].
Incubation for 1 h at 24◦C was followed by washing to
remove unbound material then incubation with substrate
for 10 min. The reaction was terminated by the addition
of sulphuric acid stop solution. Absorbance was measured
spectrophotometrically at 450 nm (Multiscan Acent; Thermo
Life Sciences, Basingstoke, UK) [13].
2.4. Validation of Integrity of H. pylori DNA after Passage
through Gut. Faecal samples previously collected from two
adults (one positive and one negative) were treated as for
DNA extraction by centrifugation and then divided into
five 1 mL fractions (A to E) to determine quantities of
culturable bacteria and the presence of H. pylori antigen.
These consisted of two samples from the creamy layer
(D and E) and three samples from the supernatant above
(A to C). The creamy layer had previously been shown to
contain a concentrated mass of bacterial cells [7]. A modified
Miles and Misra plate count was used to perform cultural
analysis [4]. The faecal fractions were serially diluted in PBS,
and 20 uL volumes were plated in triplicate onto predried
Wilkin-Chalgren anaerobic agar plates (Oxoid Ltd., UK) and
incubated at 37◦C for 24 hr in an anaerobic gas jar (Beckton
Dickinson UK Ltd., UK). The detection of H. pylori antigens
was performed using the HpSA enzyme immunoassay.
2.5. Faecal DNA Extraction and Polymerase Chain Reaction.
Six grams of defrosted faecal sample were homogenised for
2 min at room temperature with phosphate-buﬀered-saline
(0.01 M phosphate buﬀer, 0.0027 M potassium chloride,
0.317 M sodium chloride [pH 7.4] (Sigma-Aldrich, Poole,
UK) using a Stomacher 400 (Seward Medical, London, UK).
The resultant 20% (wt/vol) faecal slurry was centrifuged
at 20,000×g for 30 min (Heraeus Biofuge Stratos cen-
trifuge; Kendro Laboratory Products, Sollentum, Germany)
to concentrate the faecal flora [4]. After the removal of
the supernatant with a plastic Pasteur pipette, the creamy
phase boundary was removed to a separate 2 mL eppendorf
(Fisher Scientific UK, Leicester, UK) where an equal volume
of Prepman Ultra was added (Applied Biosystems, Cheshire,
UK). This reagent was manufactured for the specific isolation
of PCR quality DNA from foodstuﬀs and used according to
the manufacturer’s instructions.
Samples were boiled at 100◦C for 10 min in a water bath
to denature proteins and break up the bacterial cell walls
before cooling for 2 min and centrifugation at 20,000×g for
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10 min (Heraeus Biofuge Stratos) to pellet the particulates.
Organic extraction using Phenol: Chloroform: Isoamylal-
cohol (PCI) 25 : 24 : 1 (Sigma-Aldrich, Poole, UK) was
employed to extract total nucleic acids, which involved the
mixing of equal volumes of PCI and faecal supernatant
by inversion before centrifugation at 20,000×g for 5 min
(EBA 12 Centrifuge, Hettich Zentrifugen, Tuttlingen, Ger-
many). The nucleic acid containing upper aqueous phase
was transferred to a fresh 2 mL eppendorf tube, and the
process repeated twice. Traces of PCI were finally removed
in a similar fashion to the above procedure but using
chloroform (Sigma Aldrich, Poole, UK). Total nucleic acids
were recovered by ethanol precipitation using 0.1 volumes
of ice cold 3 M sodium acetate and two volumes of 100%
ethanol (Sigma-Aldrich, Poole, UK). Following mixing and
incubation on ice for 30 min, samples were centrifuged at
16,000×g for 15 min (EBA 12 centrifuge, DJB Labcare Ltd.,
Newport Pagnell, UK). After the removal of supernatant,
the samples were allowed to air dry for 30 min before
resuspension in 266 μLs of TE buﬀer (Sigma-Aldrich, Poole,
UK).
RNA was degraded by incubating with 40 U of RNAse
One (Promega, Southampton, UK) at 37◦C for 1 h before
the enzyme was removed by ethanol precipitation as previ-
ously described. Contaminating DNA was removed by gene
capture using a biotinylated oligonucleotide probe to a
specific region of the 16SrRNA gene which in H. pylori, as
in common with all unique bacterial species, displays little
allelic variation. This is so despite specific H. pylori genes
being highly polymorphic with a mean genetic diversity
of 0.83 exceeding that for all other bacterial species [2].
This involved the binding of a specific capture probe (5′
biotinylated probe: capC [5-GGG GAG TAC GGT CGC
AAG ATT AAA ACT CAA AGG AAT A-3]) (Sigma-
Aldrich, Poole UK) [15] to the H. pylori DNA followed by
overnight hybridisation. Streptavidin-coated magnetic beads
were then incubated with the hybridised complex to allow
biotin-streptavidin interaction. H. pylori DNA was separated
by electromagnetic separation from the faecal flora and
inhibitory compounds that might have interfered with sub-
sequent PCR [4]. DNA samples were stored at −20◦C until
analysis.
2.6. RAPD Analysis. A single arbitrary primed PCR primer
(1254) with sequence [5-CCGCAGCCAA-3] [10] (Sigma-
Aldrich, Poole, UK) was used to amplify segments of isolate
DNA. This allowed the visual comparison and photography
of agarose gel electrophoresis banding patterns between
isolates using Quantity One software (Bio-Rad Laboratories
Ltd., Hemel Hempstead, UK). All experiments used a
positive control (purified H. pylori DNA strain NCTC 26695)
and a negative control (faecal sample negative for H. pylori by
HpSA), processed identically to study samples. All samples,
including controls, were run in duplicate.
Amplification of gene fragments was performed with a
PTC-200 Peltier thermal cycler (MJ Research, Waltham, Mas-
sachusetts, USA). PCR amplification was performed using a
total of 50 μL reaction volume, containing 1 μL of template,
1 × buﬀer, 3 mM MgCl2, dNTP 250 μM each of dATP, dTTP,
dGTP and dCTP, 0.4 μM primer and 1.0 U of taq DNA
polymerase per reaction volume (Abgene Ltd., Epsom, UK).
This was modified from the method previously described
[10]. Thermocycling was performed under the following
conditions: 95◦C for 15 min, 94◦C for 5 min, 36◦C for 5 min
72◦C for 5 min repeated four times, followed by 94◦C for
1 min, 36◦C for 1 min, and 72◦C for 2 min repeated 30 times.
A final 10 min at 72◦C was used to finish as described previ-
ously [10]. BioNumerics software (Applied Maths NV, Sint-
Martens-Latern, Belgium) was used to assess the similarity
between lanes using the Dice coeﬃcient [16] for analysis of
RAPD genetic fingerprints of H. pylori strains produced by
gel electrophoresis. RAPD patterns were normalised using
a 0.1–1 kpb molecular size standard (Abgene Ltd., Epsom,
UK), and UPGAMA cluster analysis was performed.
3. Results and Discussion
3.1. Analysis of Culturable Bacteria and H. pylori Antigens.
In the H. pylori negative adult subject, culturable bacterial
load increased with fraction density from a mean of 8.25 ×
108 CFU/mL faecal fraction (SE 2.3 × 107) in fraction A
(9.6% total CFU/mL) to a mean of 6.2 × 109 CFU/mL faecal
fraction (SE 3.6 × 109) in fraction E (65.1% total CFU/mL).
In the H. pylori positive subject, the culturable bacterial
load increased with fraction density from a mean of 4.7 ×
106 CFU/mL faecal fraction (SE 2.5 × 106) in fraction A
(0.87% total CFU/mL) to a mean of 6.8 × 108 CFU/mL
faecal fraction (SE 2.6 × 108) in fraction E (82.5% total
CFU/mL) [4]. The numbers of culturable bacteria were in
both cases proportional to the density of the fraction. For
both individuals, the majority of all culturable bacteria were
in fraction E (Figure 2).
Antigens were detected only in the creamy layer of the
faeces of the H. pylori colonized individual (mean OD450 1.3,
SE 0.4 (negative < 0.10, equivocal ≥ 0.1 < 0.12, positive ≥
0.12)). In the H. pylori-colonized individual, the antigen
load increased with fraction density from a mean of 10.5%
total antigen in fraction A to a mean of 47.5% in fraction E
(SE 7.33) (Figure 2) suggesting that H. pylori passes through
the gut intact, since the highest H. pylori antigen signal was
found in the faecal fraction that contained the majority of the
culturable bacteria [4].
3.2. Limit of Detection of RAPD PCR. A series of dilutions
was made of a 16.16 ugs/mL stock DNA solution. This was
then used for PCR amplification in duplicate, and a gel was
run of the PCR products. The limit of detection was deter-
mined to be the dilution of the stock solution amounting to
8.08 ugs/mL, equivalent to 2.17 × 10e6 bacteria (Figure 3).
3.3. Results from Subject Samples. Twenty-six of the 28 H.
pylori study isolates that underwent RAPD typing produced
reproducible banding patterns, giving a typeability of 93%.
Of these isolates, the (1254) primer produced bands that
were highly discriminatory in all cases where there were elec-
trophoresis bands present. No two samples were identical,
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Figure 2: The percentage of total culturable bacterial cells (a, c) and H. pylori antigen signals (b, d) per faecal fraction. The data shown at
(a, b) are for the H. pylori-negative subject and at (c, d) for the H. pylori-positive subject.
Figure 3: Limit of detection of H. pylori RAPD. This photograph
displays a series of sequential dilutions of a 16.16 ugs/mL DNA
concentration. Detection of bands is good at dilutions equivalent
of 2.17 × 10e6 H. pylori bacterium.
and each varied between a high of seven and a low of one
band. Figure 4 shows the banding patterns with 2% agarose
gel electrophoresis using Quantity-One imagining software
v 4.5.0 (Bio-Rad Laboratories Ltd.). RAPD electrophoresis
banding patterns from families which had parent and child
isolates were compared in Figure 5.
All electrophoresis banding patterns gave a low degree of
homology. In Family 1, the mother’s sample (isolate 3) was
slightly more closely related to the children’s samples (isolates
2 and 4) than the father’s sample (isolate 1), 60% compared
with 40%. In Family 2, samples (isolates 5 and 6) bore a
similarity of 65%, while in family three, isolates derived from
mother and daughter (isolates 7 and 8) showed a degree of
homology with a similarity of 60%. All other parent and
sibling samples showed less than 50% similarity. Isolates
from parental stool samples are compared in Figure 6.
Isolates [1 and 3] from Family 1 had a similarity of 55%,
while samples (isolates 21 and 23) failed to produce banding
patterns and could not be compared with samples (isolates
24 and 27), respectively. Similarities between siblings were
found to be mixed (Figure 7). Isolates 2 and 4 from family
one have a similarity of 78%, while all other sibling samples
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Figure 4: RAPD typing of 28 H. pylori isolates. Analysis of banding patterns of 2% agarose gel electrophoresis using Quantity-One imagining
software v 4.5.0 (Bio-Rad Laboratories Ltd.). Lane 1, 8, 15, 22, 29, and 36 (DNA 100 bp ladder 100–1000 bp), lane 2 (negative control), lane
3 and 4 (positive culture controls), Lane 5–7, 9–14, 16–21, 23–28, 30–35, and 37 (isolates 1–28).
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Figure 5: Parent and child isolates: neighbour-joining phylogenetic
analysis of RAPD amplification of isolates using Gelcompar II
software (Applied Maths NV, Sint-Martens-Latern, Belgium). This
is a schematic representation of sample similarity: the gel bands
of each isolate (middle) are represented by vertical lines and have
been aligned to correspond with their position in the tree (left).
This tree represents the minimal total branch length at each stage of
clustering. The approximate distance between any pair of samples is
calculated from the similarity matrix (not shown).
(isolates 6 and 16, 9 and 10, and 14 and 25) showed sim-
ilarities below 50%. All single-member family isolates had
low similarity when compared with each other (Figure 8).
The closest similarity between isolates from single unrelated
members of the cohort was 62% between isolates 20 and 26,
60% between isolates 18 and 22, and 50% between isolates 17
and 28. All others were below 50% similarity.
4. Discussion
Previous studies have shown that H. pylori DNA obtained
from faecal samples can be used to successfully genotype H.
pylori DNA [4, 15]. This paper describes a method for geno-
typing H. pylori by coupling the extraction of intact genomic
DNA shed into the faeces of infected individuals with the
highly discriminatory method of RAPD. We have shown that
H. pylori passes through the gut intact by demonstrating that
Isolate 1
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Isolate 27
Isolate 21
Isolate 23
Dice (Opt: 1.12%) (Tol 1%-1%) (H > 0% S > 0%) [0%–100%]
RAPD RAPD
0 50 100
Figure 6: Parental samples: neighbour-joining phylogenetic analy-
sis of RAPD amplification of isolates using Gelcompar II software
(Applied Maths NV, Sint-Martens-Latern, Belgium).
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isolate 6
Dice (Opt: 1.12%) (Tol 1%-1%) (H > 0% S > 0%) [0%–100%]
RAPD RAPD
20 40 60 80 100
Figure 7: Sibling samples: neighbour-joining phylogenetic analysis
of RAPD amplification of isolates using Gelcompar II software
(Applied Maths NV, Sint-Martens-Latern, Belgium).
HpSA antigen detection is greatest in the centrifuged fraction
where the greatest number of culturable bacteria are located.
Genotyping of DNA recovered will, therefore, be a valid
representation of genotyping the whole bacterial genome,
and not fragments, which would otherwise have distorted the
typing results.
RAPD has proved to be an invaluable aid in the epidemi-
ological study of pathogenic bacteria in outbreaks [16, 17],
allowing the molecular characterisation of H. pylori [18].
Previous studies involving closely related H. pylori strains
obtained from gastric biopsies have shown intrafamilial dis-
persion using RAPD fingerprinting [11]. RAPD genotyping
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Figure 8: Single samples: neighbour-joining phylogenetic analysis
of RAPD amplification of isolates using Gelcompar II software
(Applied Maths NV, Sint-Martens-Latern, Belgium).
of H. pylori DNA derived from faecal samples discriminated
between all isolates that were typeable giving unique sets of
banding patterns.
In our study, similarities were low between all isolates;
the two NCTC 26695 positive control lanes were 90.9%
similar which was the maximum similarity obtained. Most
of our isolates gave a similarity of lower than 65% regardless
of whether the donors were related to each other or not.
Interestingly however, in Family 1, the two sibling samples
gave a similarity of 78% which points towards some degree
of homology between these isolates.
It was disappointing that not all HpSA-positive faecal
samples were of suﬃcient volume to permit DNA extraction.
Nevertheless, only two out of the 28 isolates tested failed to
give any type of genetic fingerprint. Some isolates produced
many bands while others only a few or even only one. One
consequence of this variation in the amount of H. pylori
isolated from each sample was that it may have lead to
diﬀering intensity of RAPD band sizes even in clonal isolates.
Fainter bands not detected by Bionumerics software could
lead to the generation of diﬀerences in similarities between
lanes. This could be eliminated in future studies by using
greater volumes of faecal material and standardizing the H.
pylori DNA extract before commencing the RAPD PCR.
Previous studies using RAPD analysis suggest that there
is a rapid accumulation of genetic variation in H. pylori [17].
In shorter term epidemiological studies, extensive genetic
variation within the pathogen of interest indicates that it
will be unlikely that any two patients will be colonised
independently with strains that give the same electrophoresis
patterns by chance. Individuals infected with strains giving
the same banding patterns are, therefore, likely to share a
common source of infection [17]. The source of H. pylori
DNA was restricted to faeces owing to ethical and practical
constraints. It is neither clinically permissible nor practically
possible to obtain gastric material from large numbers of
subjects, including children, within epidemiological studies
of families.
The identification of slight diﬀerences between DNA
fragments within clonal groups is necessary to trace patterns
of transmission in epidemiological studies. Diﬀerentiation
of unrelated isolates (discriminatory power), as well as
unambiguously providing a result for each isolate analysed
(typeability), are important performance criteria in any typ-
ing system [19]. In longer-term epidemiological studies, too
rapid accumulation of variation is a distinct disadvantage as
it could give rise to no recognisable electrophoresis patterns
as all clonality is destroyed [17]. RAPD typing provides a
method of easily producing typeable data based on familial
groupings over a short time span. Variation is likely to occur
between samples as H. pylori undergoes considerable genetic
mutation and recombination due to the pandemic nature of
this species [20].
5. Conclusions
This is the first description of a method that combines RAPD
fingerprinting and faecal H. pylori DNA extraction using
gene capture. RAPD results are promising in that isolates
from 93% of subjects gave genetic fingerprints. The use of
greater volumes of faecal material for extraction purposes
together with standardisation of extracted H. pylori DNA
before RAPD PCR might improve sensitivity. This would
help to confirm similarities between clonal isolates, and,
therefore, we would recommend this practice in further
studies. However, we have provided evidence that H. pylori
DNA obtained from faecal samples contains intact genomic
DNA, and the development of the methods described oﬀers a
promising means of studying the intrafamilial transmission
of this ubiquitous microorganism.
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